Scholtz & Company, LLC Insulet Corp Transaction History
Scholtz & Company, LLC
- $203 Million
- Q4 2024
A detailed history of Scholtz & Company, LLC transactions in Insulet Corp stock. As of the latest transaction made, Scholtz & Company, LLC holds 9,080 shares of PODD stock, worth $2.57 Million. This represents 1.16% of its overall portfolio holdings.
Number of Shares
9,080
Previous 8,411
7.95%
Holding current value
$2.57 Million
Previous $1.96 Million
21.1%
% of portfolio
1.16%
Previous 0.95%
Shares
3 transactions
Others Institutions Holding PODD
# of Institutions
754Shares Held
63.3MCall Options Held
467KPut Options Held
639K-
Vanguard Group Inc Valley Forge, PA8.49MShares$2.41 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.45MShares$2.11 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.72 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.97MShares$843 Million0.03% of portfolio
-
Baillie Gifford & CO2.36MShares$668 Million0.49% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $19.7B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...